These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13050605)

  • 1. Fatal reaction to 1-hydrazinophthalazine (apresoline).
    COHEN BM
    Am Heart J; 1953 Jun; 45(6):931-5. PubMed ID: 13050605
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical use of apresoline in the toxemias of pregnancy: a preliminary report.
    CHAPMAN ER; STROZIER WE; MAGEE RA
    Am J Obstet Gynecol; 1954 Oct; 68(4):1109-17. PubMed ID: 13197472
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.
    ASSALI NS; KAPLAN S; OIGHENSTEIN S; SUYEMOTO R
    J Clin Invest; 1953 Oct; 32(10):922-30. PubMed ID: 13096557
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral circulation and metabolism in toxemia of pregnancy; observations on the effects of veratrum viride and apresoline (1-hydrazinophthalazine).
    McCALL ML
    Am J Obstet Gynecol; 1953 Nov; 66(5):1015-30. PubMed ID: 13104502
    [No Abstract]   [Full Text] [Related]  

  • 5. Further experience with apresoline in toxemia and hypertension of pregnancy.
    RIVA HL; PICKHARDT WL; HOLZWORTH RH; SHERMAN RL
    Am J Obstet Gynecol; 1956 Jul; 72(1):48-55. PubMed ID: 13326970
    [No Abstract]   [Full Text] [Related]  

  • 6. Apresoline (hydralazine hydrochloride) and its use in cases of hypertensive pregnancy.
    JORDAN WK
    Am J Obstet Gynecol; 1954 Aug; 68(2):618-22. PubMed ID: 13180569
    [No Abstract]   [Full Text] [Related]  

  • 7. Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
    KLAYMAN MI; SILBERG NR; KARLEN WS
    N Engl J Med; 1953 Jun; 248(26):1109-11. PubMed ID: 13054899
    [No Abstract]   [Full Text] [Related]  

  • 8. Apresoline (l-hydrazinophthalazine) in the experimental eclampsia-like syndrome and related aspects of water metabolism.
    RENZI AA; GAUNT R
    Am J Physiol; 1953 Nov; 175(2):313-8. PubMed ID: 13114405
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuing vasodilator infusion therapy; utilization of a blend of 1-hydrazinophthalazine (apresoline) and cryptenamine (unitensen) in toxemia of pregnancy.
    McCALL ML
    Obstet Gynecol; 1954 Oct; 4(4):403-10. PubMed ID: 13203867
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of apresoline, veratrum alkaloids, high spinal anesthesia, and arfonad on renal hemodynamics of pregnant patients with toxemia and essential hypertension.
    KAPLAN SA; ASSALI NS
    Surg Gynecol Obstet; 1953 Oct; 97(4):501-7. PubMed ID: 13102179
    [No Abstract]   [Full Text] [Related]  

  • 11. Late systemic complications of hydralazine (apresoline) therapy.
    MULLER JC; RAST CL; PRYOR WW; ORGAIN ES
    J Am Med Assoc; 1955 Mar; 157(11):894-9. PubMed ID: 13233047
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical trial of intravenous apresoline in the management of toxaemia of late pregnancy.
    JOHNSON GT; THOMPSON RB
    J Obstet Gynaecol Br Emp; 1958 Jun; 65(3):360-6. PubMed ID: 13564276
    [No Abstract]   [Full Text] [Related]  

  • 13. Syndrome simulating collagen disease caused by hydralazine (Apresoline).
    PERRY HM; SCHROEDER HA
    J Am Med Assoc; 1954 Feb; 154(8):670-3. PubMed ID: 13117684
    [No Abstract]   [Full Text] [Related]  

  • 14. Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy.
    SHACKMAN NH; SWILLER AI; MORRISON M
    J Am Med Assoc; 1954 Aug; 155(17):1492-4. PubMed ID: 13183773
    [No Abstract]   [Full Text] [Related]  

  • 15. Late reaction to hydralazine (Apresoline) therapy.
    MANTER WB
    N Engl J Med; 1954 May; 250(19):835-6. PubMed ID: 13165907
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic effects of 1-hydrazinophthalazine in ambulatory hypertensive patients.
    WALD MH; FIERRO MI; KEETON KH
    Am Heart J; 1953 Dec; 46(6):861-4. PubMed ID: 13104328
    [No Abstract]   [Full Text] [Related]  

  • 17. Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy.
    REINHARDT DJ; WALDRON JM
    J Am Med Assoc; 1954 Aug; 155(17):1491-2. PubMed ID: 13183772
    [No Abstract]   [Full Text] [Related]  

  • 18. The action of 1-hydrazinophthalazine (hydralazine, apresoline) and the relationship between hydralazine and 5-hydroxytryptamine (enteramine, serotonine).
    NAESS K; HAKON K
    Acta Pharmacol Toxicol (Copenh); 1954; 10(2):178-98. PubMed ID: 14349710
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of 1-hydrazinophthalazine (apresoline) in the management of hypertension appearing early in pregnancy.
    FINNERTY FA
    Am J Med Sci; 1954 Aug; 228(2):140-7. PubMed ID: 13180506
    [No Abstract]   [Full Text] [Related]  

  • 20. Apresoline intolerance with bladder paralysis.
    Laurence DR; Miles NA
    N Engl J Med; 1953 Mar; 248(11):464-5. PubMed ID: 13036976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.